FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2602296492> ?p ?o ?g. }

• W2602296492 endingPage "406" @default.
• W2602296492 startingPage "397" @default.
• W2602296492 abstract "Background: Thalidomide is effective in inducing and maintaining clinical remission in children and adolescents with refractory Crohn’s disease (CD). However, little is known about the efficacy and safety of thalidomide for adult patients with CD. Methods: We conducted a prospective open-label cohort study between January 2013 and April 2015. A total of 47 adult patients with active CD who were dependent/resistant or intolerant to corticosteroids and/or immunomodulators or biologics received 50–100 mg of thalidomide daily. Primary outcome was clinical remission evaluated at week 8. Endoscopic assessment was performed at week 24 and defined as endoscopic response (decrease in Crohn’s Disease Endoscopic Index of Severity [CDEIS] score > 5 points from baseline CDEIS of 6 or more), complete endoscopic remission (CDEIS score < 3), and mucosal healing (MH) (no ulceration). Results: A total of 47 adults with active CD were enrolled. The clinical remission rate was 14.9% and 23.4% at week 4 and week 8, but increased to 46.8% at week 12 and 53.2% at week 24 out of all the 47 patients included (intention-to-treat analysis). Altogether 32 patients consented and underwent ileocolonoscopy at week 24. The rate of endoscopic response and complete endoscopic remission were 68.4% and 43.8%. MH (no ulceration) was achieved in 28.1% of patients. Adverse events occurred in 27/47 (57.4%) patients but necessitated therapy discontinuation in only 5/47 (10.6%) of patients. Conclusions: Low-dose thalidomide was effective and tolerated for inducing and maintaining clinical remission in adult patients with active CD, but the optimal time frame for thalidomide to induce clinical remission may be longer than previously appreciated and is probably optimal at 12 weeks. MH could reasonably be achievable with thalidomide." @default.
• W2602296492 created "2017-04-07" @default.
• W2602296492 creator A5003726335 @default.
• W2602296492 creator A5030511597 @default.
• W2602296492 creator A5036592420 @default.
• W2602296492 creator A5037479298 @default.
• W2602296492 creator A5039650364 @default.
• W2602296492 creator A5040582111 @default.
• W2602296492 creator A5041567436 @default.
• W2602296492 creator A5062860652 @default.
• W2602296492 creator A5072668725 @default.
• W2602296492 creator A5076035375 @default.
• W2602296492 creator A5076093051 @default.
• W2602296492 creator A5091678735 @default.
• W2602296492 date "2017-03-26" @default.
• W2602296492 modified "2023-10-18" @default.
• W2602296492 title "Thalidomide induces clinical remission and mucosal healing in adults with active Crohn’s disease: a prospective open-label study" @default.
• W2602296492 cites W1561221399 @default.
• W2602296492 cites W1580337909 @default.
• W2602296492 cites W1590601985 @default.
• W2602296492 cites W1730032611 @default.
• W2602296492 cites W1970016354 @default.
• W2602296492 cites W1989121959 @default.
• W2602296492 cites W2007171017 @default.
• W2602296492 cites W2008497900 @default.
• W2602296492 cites W2009710456 @default.
• W2602296492 cites W2026437676 @default.
• W2602296492 cites W2034229930 @default.
• W2602296492 cites W2046587660 @default.
• W2602296492 cites W2059433527 @default.
• W2602296492 cites W2061057090 @default.
• W2602296492 cites W2065491856 @default.
• W2602296492 cites W2095294682 @default.
• W2602296492 cites W2098454283 @default.
• W2602296492 cites W2118051691 @default.
• W2602296492 cites W2122207878 @default.
• W2602296492 cites W2123571431 @default.
• W2602296492 cites W2126807394 @default.
• W2602296492 cites W2143667843 @default.
• W2602296492 cites W2155459654 @default.
• W2602296492 cites W2161292867 @default.
• W2602296492 cites W2171484002 @default.
• W2602296492 cites W2179756474 @default.
• W2602296492 cites W2202486845 @default.
• W2602296492 cites W2414730407 @default.
• W2602296492 cites W2523706394 @default.
• W2602296492 cites W2556319711 @default.
• W2602296492 cites W59356990 @default.
• W2602296492 doi "https://doi.org/10.1177/1756283x17698910" @default.
• W2602296492 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5415099" @default.
• W2602296492 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28507598" @default.
• W2602296492 hasPublicationYear "2017" @default.
• W2602296492 type Work @default.
• W2602296492 sameAs 2602296492 @default.
• W2602296492 citedByCount "13" @default.
• W2602296492 countsByYear W26022964922018 @default.
• W2602296492 countsByYear W26022964922019 @default.
• W2602296492 countsByYear W26022964922020 @default.
• W2602296492 countsByYear W26022964922021 @default.
• W2602296492 countsByYear W26022964922023 @default.
• W2602296492 crossrefType "journal-article" @default.
• W2602296492 hasAuthorship W2602296492A5003726335 @default.
• W2602296492 hasAuthorship W2602296492A5030511597 @default.
• W2602296492 hasAuthorship W2602296492A5036592420 @default.
• W2602296492 hasAuthorship W2602296492A5037479298 @default.
• W2602296492 hasAuthorship W2602296492A5039650364 @default.
• W2602296492 hasAuthorship W2602296492A5040582111 @default.
• W2602296492 hasAuthorship W2602296492A5041567436 @default.
• W2602296492 hasAuthorship W2602296492A5062860652 @default.
• W2602296492 hasAuthorship W2602296492A5072668725 @default.
• W2602296492 hasAuthorship W2602296492A5076035375 @default.
• W2602296492 hasAuthorship W2602296492A5076093051 @default.
• W2602296492 hasAuthorship W2602296492A5091678735 @default.
• W2602296492 hasBestOaLocation W26022964921 @default.
• W2602296492 hasConcept C121332964 @default.
• W2602296492 hasConcept C126322002 @default.
• W2602296492 hasConcept C141071460 @default.
• W2602296492 hasConcept C142424586 @default.
• W2602296492 hasConcept C188816634 @default.
• W2602296492 hasConcept C197934379 @default.
• W2602296492 hasConcept C2776364478 @default.
• W2602296492 hasConcept C2778715236 @default.
• W2602296492 hasConcept C2779134260 @default.
• W2602296492 hasConcept C2779280984 @default.
• W2602296492 hasConcept C2779609412 @default.
• W2602296492 hasConcept C71924100 @default.
• W2602296492 hasConcept C72563966 @default.
• W2602296492 hasConcept C87355193 @default.
• W2602296492 hasConcept C90924648 @default.
• W2602296492 hasConceptScore W2602296492C121332964 @default.
• W2602296492 hasConceptScore W2602296492C126322002 @default.
• W2602296492 hasConceptScore W2602296492C141071460 @default.
• W2602296492 hasConceptScore W2602296492C142424586 @default.
• W2602296492 hasConceptScore W2602296492C188816634 @default.
• W2602296492 hasConceptScore W2602296492C197934379 @default.
• W2602296492 hasConceptScore W2602296492C2776364478 @default.
• W2602296492 hasConceptScore W2602296492C2778715236 @default.
• W2602296492 hasConceptScore W2602296492C2779134260 @default.

• next